Abstract
The Authors report their experience with the use of GnRH analogue (Goserelin) in 35 women with abnormal uterine bleeding due to low-risk hyperplasia of the endometrium. A hysteroscopic and histopathological follow-up was performed at 2 months and 6 months after treatment. The results show a significantly effectiveness of Goserelin in treating dysfunctional uterine bleeding.
MeSH terms
-
Adult
-
Delayed-Action Preparations
-
Endometrial Hyperplasia / complications
-
Endometrium / pathology
-
Female
-
Follow-Up Studies
-
Goserelin / administration & dosage
-
Goserelin / adverse effects
-
Goserelin / therapeutic use*
-
Humans
-
Hysteroscopy
-
Middle Aged
-
Recurrence
-
Uterine Hemorrhage / drug therapy*
-
Uterine Hemorrhage / etiology
Substances
-
Delayed-Action Preparations
-
Goserelin